Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | SLC25A21 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | SLC25A20 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | TRIM5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | GYPA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
mRNA | ZNF461 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | NOTCH4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | HYKK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | FAM72B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |